Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review
Crit Care. 2026 Mar 26;30(1):231. doi: 10.1186/s13054-026-05975-1.
PMID:
Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2
Vaccine. 2026 Apr 19;79:128467. doi: 10.1016/j.vaccine.2026.128467. Epub 2026 Mar 26.
PMID:
Stabilized mosaic hemagglutinin immunogens as novel universal influenza virus vaccines
Mol Ther. 2026 Mar 25:S1525-0016(26)00206-6. doi: 10.1016/j.ymthe.2026.03.021. Online ahead of print.
PMID:
Identification of a Druggable Target That Predicts Postoperative Crohn’s Disease Recurrence
Gastroenterology. 2026 Mar 16:S0016-5085(26)00233-7. doi: 10.1053/j.gastro.2026.02.035. Online ahead of print.
PMID:
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19
Nat Microbiol. 2026 Apr;11(4):1100-1112. doi: 10.1038/s41564-026-02285-8. Epub 2026 Mar 16.
PMID:
B cell imprinting in children impairs antibodies to the haemagglutinin stalk
Nature. 2026 May;653(8114):528-537. doi: 10.1038/s41586-026-10248-6. Epub 2026 Mar 11.
PMID:
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis Using Immunologic Markers
J Infect Dis. 2026 Jun 16;233(6):e1490-e1499. doi: 10.1093/infdis/jiag140.
PMID:
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adults
medRxiv [Preprint]. 2026 Feb 18:2026.02.18.26346502. doi: 10.64898/2026.02.18.26346502.
PMID:
Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adults
medRxiv [Preprint]. 2026 Feb 18:2026.02.18.26346502. doi: 10.64898/2026.02.18.26346502.
PMID:
The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response
bioRxiv [Preprint]. 2026 Feb 19:2026.02.18.706653. doi: 10.64898/2026.02.18.706653.
PMID: